Return to search results
Olanzapine
Olanzapine is a generic atypical antipsychotic medication used to treat schizophrenia and bipolar disorder. Manufactured by Aurobindo Pharma Ltd., it comes as orally disintegrating tablets in strengths of 5 mg, 10 mg, 15 mg, and 20 mg for oral use. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Olanzapine is a generic atypical antipsychotic medication used to treat schizophrenia and bipolar disorder. Manufactured by Aurobindo Pharma Ltd., it comes as orally disintegrating tablets in strengths of 5 mg, 10 mg, 15 mg, and 20 mg for oral use. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Olanzapine", "mediaType": "text/html", "description": " Access the FDA dataset for Olanzapine — ANDA 217466 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217466" } ] |
| identifier | ANDA217466 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-information", "drug-safety", "health-care", "pharmaceuticals" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Olanzapine |
